A key genetic factor for fucosyllactose utilization affects infant gut microbiota development

Nature Communications

Volumn 7, Issue , 2016, Pages

  Matsuki, Takahiro ^a   Yahagi, Kana ^a   Mori, Hiroshi ^b   Matsumoto, Hoshitaka ^a   Hara, Taeko ^a   Tajima, Saya ^a   Ogawa, Eishin ^c   Kodama, Hiroko ^c   Yamamoto, Kazuya ^b   Yamada, Takuji ^b   Matsumoto, Satoshi ^a   Kurokawa, Ken ^b,d  

^a YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^c TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NATIONAL INSTITUTE OF GENETICS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; FUCOSYLLACTOSE; LACTOSE; OLIGOSACCHARIDE; UNCLASSIFIED DRUG; 2'-FUCOSYLLACTOSE; 3'-FUCOSYLLACTOSE; TRISACCHARIDE;

BACTERIUM; CLUSTER ANALYSIS; COLONIZATION; DIGESTIVE SYSTEM; GENETIC ANALYSIS; GENOME; HEALTH IMPACT; IDENTIFICATION KEY; METABOLISM; MICROBIAL ACTIVITY; MILK;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENOME; BIFIDOBACTERIACEAE; BREAST MILK; HEREDITY; HUMAN; INFANT; INTESTINE FLORA; MICROBIAL COMMUNITY; NONHUMAN; BACTERIUM; CLASSIFICATION; FECES; GASTROINTESTINAL TRACT; GENETICS; METABOLISM; MICROBIOLOGY; NEWBORN; PHYSIOLOGY;

BIFIDOBACTERIACEAE;

BACTERIA; FECES; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; GENOME, BACTERIAL; HUMANS; INFANT, NEWBORN; OLIGOSACCHARIDES; TRISACCHARIDES;

EID: 84976385531     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms11939     Document Type: Article

References (62)

1. Fukuda, S. et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469, 543-547 (2011).
2. Stecher, B. et al. Like will to like: Abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathog. 6, e1000711 (2010).
3. Dicksved, J., Ellstrom, P., Engstrand, L. & Rautelin, H. Susceptibility to Campylobacter infection is associated with the species composition of the human fecal microbiota. MBio 5, e01212-e01214 (2014).
4. Maslowski, K. M. et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461, 1282-1286 (2009).
5. Kimura, I. et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat. Commun. 4, 1829 (2013).
6. Dogra, S. et al. Dynamics of infant gut microbiota are influenced by delivery mode and gestational duration and are associated with subsequent adiposity. MBio 6, e02419-e02414 (2015).
7. Kurokawa, K. et al. Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res. 14, 169-181 (2007).
8. Yatsunenko, T. et al. Human gut microbiome viewed across age and geography. Nature 486, 222-227 (2012).
9. Koenig, J. E. et al. Succession of microbial consortia in the developing infant gut microbiome. Proc. Natl Acad. Sci. USA 108(Suppl 1): 4578-4585 (2011).
10. Palmer, C., Bik, E. M., DiGiulio, D. B., Relman, D. A. & Brown, P. O. Development of the human infant intestinal microbiota. PLoS Biol. 5, e177 (2007).
11. Tsuji, H. et al. Molecular monitoring of the development of intestinal microbiota in Japanese infants. Benef. Microbes 3, 113-125 (2012).
12. Penders, J. et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118, 511-521 (2006).
13. Backhed, F. et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17, 690-703 (2015).
14. La Rosa, P. S. et al. Patterned progression of bacterial populations in the premature infant gut. Proc. Natl Acad. Sci. USA 111, 12522-12527 (2014).
15. Heijtz, R. D. et al. Normal gut microbiota modulates brain development and behavior. Proc. Natl Acad. Sci. USA 108, 3047-3052 (2011).
16. Cho, I. et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488, 621-626 (2012).
17. Cox, L. M. et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158, 705-721 (2014).
18. Kostic, A. D. et al. The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe 17, 260-273 (2015).
19. Caporaso, J. G. et al. QIIME allows analysis of high-Throughput community sequencing data. Nat. Methods 7, 335-336 (2010).
20. Arumugam, M. et al. Enterotypes of the human gut microbiome. Nature 473, 174-180 (2011).
21. Scardovi, V. in Bergeys Manual of Systematic Bacteriology. (eds Krieg, N. R. & Holt, J. G.) (The Williams & Wilkins Co., 1984).
22. Sela, D. A. et al. The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc. Natl Acad. Sci. USA 105, 18964-18969 (2008).
23. Wada, J. et al. Bifidobacterium bifidum lacto-N-biosidase, a critical enzyme for the degradation of human milk oligosaccharides with a type 1 structure. Appl. Environ. Microbiol. 74, 3996-4004 (2008).
24. Asakuma, S. et al. Physiology of consumption of human milk oligosaccharides by infant gut-Associated bifidobacteria. J. Biol. Chem. 286, 34583-34592 (2011).
25. Zivkovic, A. M., German, J. B., Lebrilla, C. B. & Mills, D. A. Human milk glycobiome and its impact on the infant gastrointestinal microbiota. Proc. Natl Acad. Sci. USA 108(Suppl 1): 4653-4658 (2010).
26. Matsuura, F. & Imaoka, A. Chromatographic separation of asparaginelinked oligosaccharides labeled with an ultravioletabsorbing compound, p-Aminobenzoic acid ethyl ester. Glycoconj. J. 5, 13-26 (1988).
27. Castanys-Munoz, E., Martin, M. J. & Prieto, P. A. 2-fucosyllactose: An abundant, genetically determined soluble glycan present in human milk. Nutr. Rev. 71, 773-789 (2013).
28. Albrecht, S., Schols, H. A., van den Heuvel, E. G., Voragen, A. G. & Gruppen, H. Occurrence of oligosaccharides in feces of breast-fed babies in their first six months of life and the corresponding breast milk. Carbohydr. Res. 346, 2540-2550 (2011).
29. Benno, Y., Sawada, K. & Mitsuoka, T. The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants. Microbiol. Immunol. 28, 975-986 (1984).
30. Makino, H. et al. Mother-To-infant transmission of intestinal bifidobacterial strains has an impact on the early development of vaginally delivered infants microbiota. PLoS ONE 8, e78331 (2013).
31. Lewis, Z. T. et al. Maternal fucosyltransferase 2 status affects the gut bifidobacterial communities of breastfed infants. Microbiome 3, 13 (2015).
32. Sela, D. A. & Mills, D. A. Nursing our microbiota: molecular linkages between bifidobacteria and milk oligosaccharides. Trends Microbiol. 18, 298-307 (2010).
33. Ruiz-Moyano, S. et al. Variation in consumption of human milk oligosaccharides by infant-gut associated strains of Bifidobacterium breve. Appl. Environ. Microbiol. 79, 6040-6049 (2013).
34. Lee, S. M., Donaldson, G. P., Mikulski, Z., Boyajian, S., Ley, K. & Mazmanian, S. K. Bacterial colonization factors control specificity and stability of the gut microbiota. Nature 501, 426-429 (2013).
35. Asahara, T., Shimizu, K., Nomoto, K., Hamabata, T., Ozawa, A. & Takeda, Y. Probiotic bifidobacteria protect mice from lethal infection with Shiga toxinproducing Escherichia coli O157:H7. Infect. Immun. 72, 2240-2247 (2004).
36. Samuel, B. S. et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-Acid binding G protein-coupled receptor, Gpr41. Proc. Natl Acad. Sci. USA 105, 16767-16772 (2008).
37. Kimura, I. et al. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc. Natl Acad. Sci. USA 108, 8030-8035 (2011).
38. Kamada, N., Chen, G. Y., Inohara, N. & Nunez, G. Control of pathogens and pathobionts by the gut microbiota. Nat. Immunol. 14, 685-690 (2013).
39. Matsuki, T. et al. Quantitative PCR with 16S rRNA-gene-Targeted speciesspecific primers for analysis of human intestinal bifidobacteria. Appl. Environ. Microbiol. 70, 167-173 (2004).
40. Marchesi, J. R. et al. Design and evaluation of useful bacterium-specific PCR primers that amplify genes coding for bacterial 16S rRNA. Appl. Environ. Microbiol. 64, 795-799 (1998).
41. Lane, D. J. in Nucleic Acid Techniques in Bacterial Systematics. (eds Stackebrandt, E. & Goodfellow, M.) (John Wiley & Sons Ltd., 1991).
42. Cole, J. R. et al. Ribosomal Database Project: data and tools for high throughput rRNA analysis. Nucleic Acids Res. 42, D633-D642 (2013).
43. Mori, H. et al. Design and experimental application of a novel non-degenerate universal primer set that amplifies prokaryotic 16S rRNA genes with a low possibility to amplify eukaryotic rRNA genes. DNA Res. 21, 217-227 (2014).
44. Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460-2461 (2010).
45. Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C. & Knight, R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27, 2194-2200 (2011).
46. Haas, B. J. et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res. 21, 494-504 (2011).
47. Wang, Q., Garrity, G. M., Tiedje, J. M. & Cole, J. R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73, 5261-5267 (2007).
48. Edgar, R. C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32, 1792-1797 (2004).
49. Price, M. N., Dehal, P. S. & Arkin, A. P. FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol. Biol. Evol. 26, 1641-1650 (2009).
50. Kaufman, L. & Rousseeuw, P. J. in Partitioning Around Medoids (Program PAM), Finding Groups in Data: An Introduction to Cluster Analysis (John Wiley & Sons Inc., 1990).
51. Calinski, T. & Harabasz, J. A dendrite method for cluster analysis. Commun. Stat. 3, 1-27 (1974).
52. Matsumoto, K. et al. Effects of a probiotic fermented milk beverage containing Lactobacillus casei strain Shirota on defecation frequency, intestinal microbiota, and the intestinal environment of healthy individuals with soft stools. J. Biosci. Bioeng. 110, 547-552 (2006).
53. Akopyanz, N., Bukanov, N. O., Westblom, T. U., Kresovich, S. & Berg, D. E. DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting. Nucleic Acids Res. 20, 5137-5142 (1992).
54. Simpson, J. T., Wong, K., Jackman, S. D., Schein, J. E., Jones, S. J. & Birol, I. ABySS: A parallel assembler for short read sequence data. Genome Res. 19, 1117-1123 (2009).
55. Fanning, S. et al. Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc. Natl Acad. Sci. USA 109, 2108-2113 (2012).
56. Delcher, A. L., Bratke, K. A., Powers, E. C. & Salzberg, S. L. Identifying bacterial genes and endosymbiont DNA with glimmer. Bioinformatics 23, 673-679 (2007).
57. Altschul, S. F. et al. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 25, 3389-3402 (1997).
58. Kanehisa, M., Goto, S., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res. 42, D199-D205 (2014).
59. Li, L., Stoeckert, Jr. C. J. & Roos, D. S. OrthoMCL: identification of ortholog groups for eukaryotic genomes. Genome Res. 13, 2178-2189 (2003).
60. Larkin, M. A. et al. Clustal W and Clustal X version 2.0. Bioinformatics 23, 2947-2948 (2007).
61. Ventura, M. et al. Analysis of bifidobacterial evolution using a multilocus approach. Int. J. Syst. Evol. Microbiol. 56, 2783-2792 (2006).
62. Kiwaki, M. & Sato, T. Antimicrobial susceptibility of Bifidobacterium breve strains and genetic analysis of streptomycin resistance of probiotic B. breve strain Yakult. Int. J. Food Microbiol. 134, 211-215 (2009).